Advanced Biomed ADVB
NASDAQ ADVB
$9.50 +0.26 (+2.81%)
As of: Aug 27, 2026 · 3:59 PM EDT

Advanced Biomed (ADVB) Return on Capital Employed (2025 - 2026)

Advanced Biomed (ADVB) posted Return on Capital Employed of 120.92% for Q1 2026, down 21.5% sequentially from 154.04% in Q4 2025, and down 4020.0% YoY from 3.08% in Q1 2025.

Advanced Biomed (ADVB) Return on Capital Employed (2025 - 2026) Analysis & Trends

Advanced Biomed has reported Return on Capital Employed for 2 years, with the latest figure at 120.92% in Q1 2026.

  • Quarterly Return on Capital Employed fell 4020.0% year-over-year to 120.92% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 120.92% (down 4020.0% YoY) and the FY2025 annual result came in at 159.13%, changed N/A from the prior year.
  • Return on Capital Employed declined to 120.92% in Q1 2026 per ADVB's latest filing, from 154.04% in the prior quarter.
  • Over five years, Return on Capital Employed peaked at 161.12% in Q1 2025 and troughed at 58.06% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Thermo Fisher Scientific 234.15 Bn 230.09 Bn 8.34 Bn 8.30%
2 Danaher 152.10 Bn 147.75 Bn 3.61 Bn 6.42%
3 Natera 48.48 Bn 47.38 Bn 486.15 Mn -13.91%
4 Agilent Technologies 44.35 Bn 42.55 Bn 990.00 Mn 14.57%
5 Iqvia Holdings 43.68 Bn 41.60 Bn 1.44 Bn 10.49%
6 Idexx Laboratories 43.02 Bn 42.83 Bn 779.09 Mn 68.60%
7 Illumina 34.39 Bn 33.22 Bn 770.00 Mn 17.55%
8 Mettler Toledo International 28.29 Bn 28.24 Bn 650.22 Mn 49.80%
9 Labcorp Holdings 27.51 Bn 27.37 Bn 1.11 Bn 8.97%
10 Advanced Biomed 12.28 Mn 12.28 Mn - 49.66%

Historic Data

Download Data
DateValue
Mar 31, 2026 49.66%
Dec 31, 2025 53.76%
Sep 30, 2025 -52.78%
Jun 30, 2025 -389.74%
Mar 31, 2025 -124.95%